Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis

Journal of Dermatological Treatment

Volumn 16, Issue 5-6, 2005, Pages 327-330

  Avner, Shemer ^a   Nir, Nathansohn ^b   Henri, Trau ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Ciclopirox; Onychomycosis; Terbinafine

Indexed keywords

CICLOPIROX; TERBINAFINE;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DERMATOPHYTE; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; ONYCHOMYCOSIS; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADULT; ANTIFUNGAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NAPHTHALENES; ONYCHOMYCOSIS; PYRIDONES; TREATMENT OUTCOME;

EID: 31644438979     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630500420183     Document Type: Article

References (13)

1. Baran R, Kaoukhov A. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venereol. 2005;19:21-9.
2. Elewski BE. Onychomycosis: pathogenesis, diagnosis, and management. Clin Microbiol Rev. 1998;11:415-29.
3. Gupta AK, Ryder JE, Baran R. The use of topical therapies to treat onychomycosis. Dermatol Clin. 2003;21:481-9.
4. Evans EG. Drug synergies and the potential for combination therapy in onychomycosis. Br J Dermatol. 2003;149(Suppl 65), 11-13.
5. Gupta AK, Ryder JE, Skinner AR. Treatment of onychomycosis: pros and cons of antifungal agents. J Cutan Med Surg. 2004;8:25-30.
6. Olafsson JH, Sigurgeirsson B, Baran R. Combination therapy for onychomycosis. Br J Dermatol. 2003;149(Suppl 65), 15-18.
7. Roberts DT, Taylor WD, Boyle J. Guidelines for treatment of onychomycosis. Br J Dermatol. 2003;148:402-10.
8. Bohn M, Kraemer KT. Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis. J Am Acad Dermatol. 2000;43:S57-S69.
9. Seebacher C. Action mechanisms of modern antifungal agents and resulting problems in the management of onychomycosis. Mycoses. 2003;46:506-10.
10. Gupta AK. Ciclopirox nail lacquer: a brush with onychomycosis. Cutis. 2001;68:13-16.
11. Gupta AK, Ryder JE, Johnson AM. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Br J Dermatol. 2004;150:537-44.
12. Gupta AK, Lynch LE. Management of onychomycosis: examining the role of monotherapy and dual, triple, or quadruple therapies. Cutis. 2004;74:5-9.
13. aran R, de Doncker P. Lateral edge nail involvement indicates poor prognosis for treating onychomycosis with the new systemic antifungals. Acta Derm Venereol. 1996;76:82-3.